Cancer Cells Downloads
-
Highplex - Version FL - Cell-Based Analysis Module - Brochure
Indica Labs’ Highplex FL module allows for simultaneous analysis of an unlimited number of fluorescent markers in any cellular compartment – nucleus, cytoplasm, and/or membrane. With the option to define specific cell phenotypes according to marker positivity, this module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize ...
-
Modulight - Model ML8500 - Automatic Biomedical Illumination Kit - Brochure
ML8500 is an automatic biomedical illumination kit that works seamlessly with Modulight’s ML7710 biomedical laser or optional internal ML6600 series lasers. Modulight customers are using our in-vitro products as their everyday tools helping with their research by providing controlled and repeatable illumination. Read an application note about in-vitro cell viability and dose escalation ...
-
Analysis of Exosomal Protein Expression
Exosomes can affect cell functions by transferring substances such as nucleic acids, proteins, and lipids between cells. For example, they play an important role in the process of antigen presentation in antigen-presenting cells, in the development of tumor cells, and in signal transduction in nerve cells. ...
-
BriaCell - Corporate Highlights - Datasheet
BriaCell Therapeutics Corp. is a clinical stage immunotherapy company developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous ...
-
BriaCell Therapeutics - Presentation
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy cancer cells, offer the potential ...
-
Chemoscale - Model 360 - Chemo - Resistance Profiling Technology for Circulating Tumor Associated Cells - Brochure
Chemo-scale is an advanced non-invasive test which provides therapeutically relevant information and is based on a safe, simple, and quick blood draw. Chemo-scale™ investigates in vitro chemo-resistance in Circulating Tumor Associated Cells (CTACs) isolated from the blood sample. CTACs include cancer cells that escape from the tumor and enter the bloodstream (circulating tumor cells, CTCs) ...
-
Cancertrack - Model 360 - Cancer Treatments Technology - Brochure
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ (CTCs). ...
-
Pinaka - Model 360 - Theranostic Profiling Technology for Circulating Tumor Cells - Brochure
Pinaka™ is an advanced non-invasive blood test which provides therapeutically relevant information via a safe, simple and quick blood draw. Pinaka™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Pinaka™ enriches these CTCs from the blood sample and confirms their ...
-
Optical Q - Immunoassay For the Quantitative Determination of beta-hCG - Brochure
Optical Q beta-hCG is an in vitro diagnostic medical device that quantify Beta-Human Chorionic gonadotropin (beta-hCG) in human serum or plasma using immunofluorescence. This helps to diagnose or monitor for pregnancy, trophoblastic disease, or germ cell ...
-
Isotopia - Model Lu-177 - Theranostic Isotope Kit Brochure
Lutetium-177 (Lu-177) is being widely used as a promising radionuclide for targeted therapy and is emerging as a game-changing theranostic isotope for the treatment of neuroendocrine tumors, metastatic castration-resistant prostate cancer (mCRPC) along with its development for new carrier molecules that can provide selective targeting for tumor sites. ...
-
Explore Cancer-related Mutations with NGS
Further mutations may occur in the progeny of the cancer cell, leading to the development of tumour cell invasion and metastasis. The application of NGS provides a high-resolution and global view of the cancer genome in a high throughput manner, revealing several novel cancer-related genes and pathways. ...
By CD Genomics
-
Novodiax - Model CD45 Ab - Antibody for Body Fluid & FNA - Brochure
Cluster of Differentiation 45 (CD45) pHRP Anti-Human Staining Kit immunohistochemistry (IHC) reagent is for use on frozen and formalin-fixed-paraffin-embedded tissues. The CD45 antigen is a protein which was originally called Leukocyte Common Antigen and recognizes an antigen found on lymphoid cells. Anti-CD45 antibody is a useful tool for identifying tumor cells of lymphoid origin. It is ...
-
Novodiax - Model CD45 Ab - Rapid IHC Panel - Brochure
Cluster of Differentiation 45 (CD45) pHRP Anti-Human Staining Kit immunohistochemistry (IHC) reagent is for use on frozen and formalin-fixed-paraffin-embedded tissues. The CD45 antigen is a protein which was originally called Leukocyte Common Antigen and recognizes an antigen found on lymphoid cells. Anti-CD45 antibody is a useful tool for identifying tumor cells of lymphoid origin. ...
-
CD13 iFluor - Model 488 - Cell Surface CD13 Antigen - Datasheet
Clone APN1464 recognizes cell surface CD13 antigen, a 150kDa membrane glycoprotein. The CD13 antigen is highly expressed mostly on myeloid-derived hematopoietic cells including granulocytes, monocytes, mast cells, and GM-progenitor cells. CD13 abundantly expresses on most of the malignant cells of myeloid origin such as AML, CML and also on smaller subset of cancer cells of lymphoid origin. ...
-
Target Enrichment with SRSLY and Twist Exome Panel - Brochure
SRSLY NGS library preparation with twist exome panel enrichment for ctDNA SNP profiling. Cell-free DNA (cfDNA), found circulating in blood, originates predominantly from dying cells. In healthy individuals the vast majority of cfDNA derives from hematopoietic myeloid and lymph cells undergoing apoptosis. However, in individuals with cancer, a variable fraction of the cfDNA derives from tumor ...
-
OncoDEEP Brochure
Oncodeep® is a comprehensive biomarker test designed to guide treatment of advanced, metastatic solid tumors. When your patients are diagnosed with a rare cancer type or an aggressive cancer, when chemotherapy doesn't work or when cancer comes back, OncoDEEP® can provide you with clear clinical guidance. Starting from a small sample of tumor tissue, our biomarker test is able to pinpoint ...
By OncoDNA S.A.
-
ISET Technology Brochure
ISET®, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority of leukocytes. ISET system successfully captures CTCs that are presenting, by definition, heterogeneous phenotypic profiles ...
-
Sword Assay for Human VEGF - Brochure
Vascular endothelial growth factor (VEGF) was identified as a cell specific mitogen, and a mediator of both angiogenesis and vasculogenesis.1 It contributes to the development of tumors, and elevated levels of VEGF production are able to be detected in tumor cells at the extreme periphery of the tumor.2 In response to tumor-induced hypoxia there have been high levels of VEGF found in various ...
-
CellSieve - Isolation of Circulating Cancer Associated Cells - Brochure
Circulating tumor cells (CTCs) and cancer-associated macrophage-like cells (CAMLs) provide a minimally invasive alternative to tissue biopsy to determine cancer therapy and monitor treatment response and recurrence [Adams, et al., PNAS 2014; Adams, et al., Cytometry 2014]. Cancer associated cells collected on CellSieveTM microfilters are applicable for companion diagnostics and drug development. ...
-
Caprico - Model EGFR - Anti Biotin- Brochure
The clone 528, a mouse monoclonal antibody, specifically reacts with an epitope of the ~170 kDa extracellular protein domain of human epidermal growth factor receptor or commonly known as EGFR. Physiologically EGFR is expressed in the skin, gastrointestinal system, kidney, and other normal tissues as well as aberrantly over expresses in epithelial cancer cells of lung, pancreas, colon, breast, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you